Page last updated: 2024-08-22

platinum and sc002

platinum has been researched along with sc002 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Appenzeller, C; Bar, J; Cho, BC; Colinet, B; Gottfried, M; Gutierrez, V; Helland, A; Hung, JY; Johnson, ML; Komarnitsky, P; Laktionov, K; Lena, H; Luo, Y; Maag, D; Nickner, C; Okamoto, I; Rich, P; Sun, Z; Vajikova, A; van der Leest, C; Wolf, M; Zvirbule, Z	1

Trials

1 trial(s) available for platinum and sc002

Article	Year
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021, Volume: 16, Issue:9 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Double-Blind Method; Humans; Immunoconjugates; Lung Neoplasms; Middle Aged; Platinum	2021

Article

Year

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021, Volume: 16, Issue:9

Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepinones; Double-Blind Method; Humans; Immunoconjugates; Lung Neoplasms; Middle Aged; Platinum

2021